• Mashup Score: 0

    In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show. Pulsed field ablation (PFA) is a novel AF ablation modality that has demonstrated preferential tissue ablation with no esophageal damage in early clinical trials, Vivek Y. Reddy, MD, director of

    Tweet Tweets with this article
    • ICYMI: “It’s quite striking. The most optimized version has a high degree of durability. This translated to good clinical success — 1 year freedom from AF, atrial flutter and atrial tachycardia” @VivekReddyMD @MountSinaiNYC #EHRA2023 #EPeeps #cardiotwitter https://t.co/i7MkGgosod

  • Mashup Score: 2

    An exploratory LOOP study analysis hints that screening is more likely to help avert stroke if patients have elevated biomarkers.

    Tweet Tweets with this article
    • "If we bother screening for #AFib, we should probably think about screening the part of the population that has a higher proBNP and not worry about the population with a lower proBNP," @SZDiederichsen says @TCTMD @lucas_yxing #LOOPstudy #EHRA2023 https://t.co/lnZjjxFGkl

  • Mashup Score: 0

    In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show. Pulsed field ablation (PFA) is a novel AF ablation modality that has demonstrated preferential tissue ablation with no esophageal damage in early clinical trials, Vivek Y. Reddy, MD, director of

    Tweet Tweets with this article
    • ICYMI: “It’s quite striking. The most optimized version has a high degree of durability. This translated to good clinical success — 1 year freedom from AF, atrial flutter and atrial tachycardia” @VivekReddyMD @MountSinaiNYC #EHRA2023 #EPeeps #cardiotwitter https://t.co/i7MkGgosod

  • Mashup Score: 0

    In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show. Pulsed field ablation (PFA) is a novel AF ablation modality that has demonstrated preferential tissue ablation with no esophageal damage in early clinical trials, Vivek Y. Reddy, MD, director of

    Tweet Tweets with this article
    • In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year @VivekReddyMD @MountSinaiNYC #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/i7MkGgosod

  • Mashup Score: 0

    The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.The score utilized readily available clinical values including QRS width, known etiology, AF subtype and atrial dilation to identify those who may experience improved left ventricular ejection fraction after AF

    Tweet Tweets with this article
    • ICYMI: “The ANTWERP score was developed to predict the response to ablation in heart failure patients with impaired (below 50%) ejection fraction.” #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/QbapWrLJqs

  • Mashup Score: 0

    In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of

    Tweet Tweets with this article
    • ICYMI: “After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” #AFib #EHRA2023 #EPeeps #EHRA_ESC https://t.co/Fxvrd9WrE4

  • Mashup Score: 0

    The novel ANTWERP score demonstrated good predictive value in identifying patients whose heart failure symptoms would improve after ablation for atrial fibrillation, a speaker reported.The score utilized readily available clinical values including QRS width, known etiology, AF subtype and atrial dilation to identify those who may experience improved left ventricular ejection fraction after AF

    Tweet Tweets with this article
    • ICYMI: “The ANTWERP score was developed to predict the response to ablation in heart failure patients with impaired (below 50%) ejection fraction.” #AFib #EHRA2023 #EPeeps #EHRA_ESC #cardiotwitter https://t.co/QbapWrLJqs

  • Mashup Score: 0

    In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.“After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” Nicolas Derval, MD, head of

    Tweet Tweets with this article
    • ICYMI: “After 10 months of follow up, the success rate in the Marshall-Plan group was significantly better (87%) compared to the PVI only group (70%),” #AFib #EHRA2023 #EPeeps #EHRA_ESC https://t.co/Fxvrd9WrE4